In € million

 

 

 

FY 2018

 

FY 2017

IFRS research & development costs

 

a

 

(297)

 

(290)

Grants netted in research & development costs

 

b

 

25

 

26

Depreciation, amortization & impairments included in research & development costs

 

c

 

(59)

 

(55)

Capex in research & innovation

 

d

 

(89)

 

(64)

Research & innovation

 

e = a-b-c+d

 

(352)

 

(325)

Advanced Materials

 

 

 

(171)

 

(157)

Advanced Formulations

 

 

 

(97)

 

(85)

Performance Chemicals

 

 

 

(27)

 

(29)

Corporate & Business Services

 

 

 

(58)

 

(55)

Net sales

 

f

 

10,257

 

10,125

Advanced Materials

 

 

 

4,385

 

4,370

Advanced Formulations

 

 

 

3,057

 

2,966

Performance Chemicals

 

 

 

2,808

 

2,766

Corporate & Business Services

 

 

 

7

 

23

Research & Innovation intensity

 

g = -e/f

 

3.4%

 

3.2%

Advanced Materials

 

 

 

3.9%

 

3.6%

Advanced Formulations

 

 

 

3.2%

 

2.9%

Performance Chemicals

 

 

 

1.0%

 

1.0%

Research an innovation efforts amounted to €352 million in 2018. The global expenditure analysis clearly underlines that innovation projects are generally focused on growth (74% of total R&I efforts).

Some 84% of the Group’s Research & Innovation investments are directly managed by the Global Business Units.

The Research & Innovation intensity, i.e. the ratio of Research & Innovation efforts to net sales reached 3.4%.